MENU
+Compare
HFXI
ETF ticker: NYSE ARCA
AS OF
Dec 24 closing price
Price
$32.47
Change
+$0.12 (+0.37%)
Net Assets
1.18B

HFXI stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the FTSE Developed ex North America 50% Hedged to USD Index... Show more

HFXI
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for HFXI with price predictions
Dec 24, 2025

HFXI sees its Stochastic Oscillator ascending out of oversold territory

On December 24, 2025, the Stochastic Oscillator for HFXI moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

HFXI moved above its 50-day moving average on November 25, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HFXI advanced for three days, in of 331 cases, the price rose further within the following month. The odds of a continued upward trend are .

HFXI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 319 cases where HFXI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HFXI moved out of overbought territory on December 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 48 similar instances where the indicator moved out of overbought territory. In of the 48 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HFXI as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HFXI turned negative on December 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HFXI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Boeing Company (NYSE:BA), BHP Group Limited (NYSE:BHP), Newmont Corp (NYSE:NEM), BP plc (NYSE:BP), Allergan plc (NYSE:AGN), Suncor Energy (NYSE:SU), JD.com (NASDAQ:JD), Prudential Financial (NYSE:PRU).

Industry description

The investment seeks investment results that correspond generally to the price and yield performance of its underlying index, the FTSE Developed ex North America 50% Hedged to USD Index. The underlying index is an equity benchmark of international stocks from developed markets, with approximately half of the currency exposure of the securities included in the underlying index "hedged" against the U.S. dollar on a monthly basis. The fund invests, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the securities and other instruments included in its underlying index.

Market Cap

The average market capitalization across the NYLI FTSE International Eq Ccy Netrl ETF ETF is 42.83B. The market cap for tickers in the group ranges from 64.65K to 411.55B. ASML holds the highest valuation in this group at 411.55B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the NYLI FTSE International Eq Ccy Netrl ETF ETF was 0%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 11%. GLE experienced the highest price growth at 15%, while RAND experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the NYLI FTSE International Eq Ccy Netrl ETF ETF was -56%. For the same stocks of the ETF, the average monthly volume growth was -62% and the average quarterly volume growth was -67%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 48
Price Growth Rating: 49
SMR Rating: 63
Profit Risk Rating: 58
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
HFXI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Fundamentals
Details
Category
Foreign Large Blend
Address
800 Westchester Avenue,Suite N611Rye Brook
Phone
1-888-934-0777
Web
www.indexiq.com